新型2,4,6,-取代嘧啶衍生物的设计、合成和抗肿瘤活性研究

为了寻找高效的新型抗肿瘤药物,设计合成了一系列2,4,6-取代嘧啶衍生物,并使用噻唑蓝(MTT)法对4种人的肿瘤细胞人结肠癌细胞(SW-620)、人前列腺癌细胞(PC-3)、人非小细胞肺癌细胞(A549)和人胃癌细胞(MGC-803)进行了体外抗肿瘤活性研究.其中化合物N-((4-乙基苯基)氨基甲酰基)-2-((4-(...     

取代喹啉类化合物抗菌活性的3D-QSAR研究及分子设计

通过比较分子力场分析方法(Co MFA)研究取代喹啉类化合物对金黄色葡萄球菌抑菌活性(p M)的三维定量结构-活性相关(3D-QSAR)。12个化合物建立了预测模型,7个化合物作为验证集(含模板分子)。训练集的Co MFA模型显示立体场、静电场对生物活性贡献依次为49.8%、50.2%。该模型的交叉验证相关系数R2cv=0.650,非交叉验证相关系数R2=0.918,对测试集中的7个化合物的生物活性进行了预测,显示出较强的稳定性和良好的预测能力。通过分析Co MFA三维等势图发现,在取代喹啉类化合物抑菌机理中,R4取代基的强吸电性起主要作用,其次是其他取代基的疏水性作用。应用上述规律进行分子设计,获得了3个在理论上具有较高抑菌活性的新的取代喹啉衍生物,期待实验的验证。     

含磷嘧啶类CDK9抑制剂的分子对接、3D-QSAR和分子动力学模拟

选取64个具有潜力的含磷嘧啶类细胞周期依赖性蛋白激酶(CDK9)小分子抑制剂,采用分子对接方法研究了该类小分子与CDK9的结合作用,结果表明,分子构象、氢键形成、疏水性和氨基酸残基Cys106在此类抑制剂与CDK9的结合过程中具有重要作用.在配体叠合的基础上,运用比较分子力场分析(Co MFA)、比较分子相似性指数分析(Co MSIA)和Topomer Co MFA(T-COMFA)研究了分子结构与抑制活性的关系,发现由训练集立体场、静电场和疏水场组合的Co MSIA模型为最优模型,其内部交叉验证相关系数(Q2=0.557)、非交叉验证相关系数(R2=0.959)和外部预测相关系数(r2=0.863)具有统计学意义,该模型的三维等值线图直观显示了化合物的活性与其三维结构的关系.根据这些结果设计了10个具有新结构的含磷嘧啶类化合物,分子对接和分子动力学模拟结果表明,新化合物和CDK9的结合模式与原化合物64相同,自由能分析从理论上证明了新化合物64d的CDK9抑制活性优于化合物64,并且显示含磷基团与残基Asp109的静电场能在化合物与CDK9作用过程中有重要作用.     

吡啶并嘧啶衍生物抗乳腺癌活性的CoMFA模型

基于比较分子力场分析(CoMFA)方法建立25种吡啶并嘧啶衍生物抗乳腺癌活性(pIC)的三维定量构效关系(3D-QSAR)。训练集中20个化合物用于建立预测模型,测试集6个化合物(含模板分子)作为模型验证。已建立的CoMFA模型的交叉验证系数(R_cv²)、非交叉验证系数(R²)分别为0.467、0.891,说明所建模型具有较强的稳定性和良好的预测能力。该模型中立体场、静电场对pIC的贡献率依次为40.8%、59.2%。基于此研究结果,设计了4个具有较高抗乳腺癌活性的新化合物,有待医学实验验证。     

抗癌性吲哚喹唑啉衍生物3D-QSAR研究及其分子设计

吲哚喹唑啉衍生物是近年来发现的一类具有良好抗癌活性的化合物. 作者在最近报道的二维定量构效关系(2D-QSAR)的基础上, 采用比较分子力场方法(CoMFA)进一步对该系列化合物进行三维定量构效关系(3D-QSAR)研究, 建立了3D-QSAR的CoMFA模型, 其非交叉验证相关系数r2=0.986, 标准偏差SD=0.084, 统计方差比F=114.6, 交叉验证相关系数q2=0.695, 表明该模型合理、可信, 并具有良好的预测能力. 研究结果表明: (1) 取代基R1的部位上静电效应起主要作用, 并且确保取代基R1的第一个原子具有较大的净正电荷, 对提高化合物的抗癌活性十分重要. 这与2D-QSAR研究结果相一致. (2) 取代基R2的部位上立体效应起主要作用, R2的体积大小要适中. 应用这些规律进行了分子设计, 在理论上获得了一些具有较高抗癌活性的新的吲哚喹唑啉衍生物, 并期待实验证实. 该QSAR的研究结果可为实验工作者合成新药提供理论参考.     

培氟沙星均三唑硫醚衍生物抗肝癌活性的CoMFA模型与分子设计

基于比较分子力场分析(CoMFA)方法建立24种培氟沙星均三唑硫醚衍生物抗肝癌活性(pM)的三维定量构效关系(3D-QSAR)。训练集中20个化合物用于建立预测模型,测试集10个化合物(含模板分子及新设计的5个分子)作为模型验证。所建立的3D-QSAR模型的交叉验证系数(R_cv²)、非交叉验证系数(R²)分别为0.705、0.940,说明模型具有较强的稳定性和良好的预测能力。该模型中立体场、静电场贡献率依次为74.8%、25.2%,表明影响抗肝癌活性(pM)的主要因素是取代基的疏水性和空间契合,其次是库仑力、氢键及配位。基于三维等势图,设计了5个具有较高抗肝癌活性的分子,有待医学实验验证。     

苯并嗪酮衍生物的3D-QSAR分析

苯并嗪酮衍生物是近年来发现的一类抗血小板聚集化合物, 在前人研究的基础上利用比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)对23个苯并嗪酮衍生物进行了三维定量构效关系(3D-QSAR)研究. 其中CoMFA模型交叉验证系数Q2=0.703, 回归系数R2=0.994, 计算值与实验值的平均方差SEE=0.053, 统计方差比F=184.773; CoMSIA模型Q2=0.847, R2=0.992, SEE=0.058, F=171.670. 两种方法得到的模型都具有较好的预测能力. 结果表明, 标题化合物中8-位取代基R1静电效应起主要作用; 2-位取代基R2立体效应占主导作用, 但官能团大小要适中. 根据研究结果设计了六种活性较高的化合物.     

含嘧啶氨基的三取代三嗪衍生物的合成及其抗菌、抗肿瘤活性研究

以三聚氯氰为起始原料,合成了系列新的含嘧啶氨基的2,4,6-三取代-1,3,5-三嗪化合物,并测试了化合物抗苹果树腐烂病菌和抑制肿瘤细胞增殖活性.结果表明,化合物2aa～2cb及3aa～3cb对苹果树腐烂病菌具有显著的抑制作用,具有开发为新型植物抗菌剂的潜力.部分化合物,如4ba和4ca分别对胃癌(BGC-823)和宫颈癌(Hela)肿瘤细胞具有较强的抑制活性,IC50分别为10.9和11.3μmol/L.     

新型嘧啶单环类非经典叶酸拮抗剂的合成及抗肿瘤活性研究

以课题组前期设计合成的非经典叶酸拮抗剂6-(4'-甲基苯乙基)-N5-氯乙酰基-2,4-二氨基哌啶并[3,2-d]嘧啶(wm-8.2)为先导化合物,将wm-8.2中的哌啶并嘧啶双环结构简化为嘧啶单环结构,以提高分子柔韧性并简化分子结构,根据6-位空间占位设计6-H和6-甲基两个系列,考察了不同桥链长度和不同芳香杂环侧链...     

苯并噁嗪酮衍生物的3D-QSAR分析

苯并噁嗪酮衍生物是近年来发现的一类抗血小板聚集化合物,在前人研究的基础上利用比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)对23个苯并噁嗪酮衍生物进行了三维定量构效关系(3D-QSAR)研究.其中CoMFA模型交叉验证系数Q2=0.703,回归系数R2=0.994,计算值与实验值的平均方差SEE=0.053,统计方差比F=184.773;CoMSIA模型Q2=0.847,R2=0.992,SEE=0.058,F=171.670.两种方法得到的模型都具有较好的预测能力.结果表明,标题化合物中8-位取代基R1静电效应起主要作用;2-位取代基R2立体效应占主导作用,但官能团大小要适中.根据研究结果设计了六种活性较高的化合物.     

3D‐QSAR studies and molecular design on a novel series of pyrimidine benzimidazoles as Lck inhibitors

The development of selective lymphocyte‐specific kinase (Lck) inhibitors has attracted much attention for the research of the treatment of T‐cell mediated autoimmune and inflammatory diseases. In the present work, three‐dimensional quantitative structure–activity relationship (3D‐QSAR) analyses are performed on a novel series of 4‐amino‐6‐benzimidazole‐pyrimidines acting as Lck inhibitors. The established 3D‐QSAR models show significant statistical quality and satisfactory predictive ability, with high q² and R² values: the comparative molecular field analysis (CoMFA) model (q² = 0.802, R² = 0.991), and the comparative molecular similarity indexes analysis (CoMSIA) model (q² = 0.731, R² = 0.982). The systemic external validation indicates that both CoMFA and CoMSIA models are quite robust and possess high predictive abilities with values of 0.881 and 0.877, values of 0.897 and 0.847, values of 0.897 and 0.850, and values of 0.897 and 0.854, respectively. Several key structural features accounting for the inhibitory activities of these compounds are discussed. Based on established models and design considerations, six new compounds with significantly improved activities are theoretically designed, which still await experimental confirmation and evaluation. These theoretical results may provide a useful reference for understanding the action mechanism and designing novel potential Lck inhibitors. © 2014 Wiley Periodicals, Inc.     

Synthesis and fungicidal activity of novel 1,2,4-triazole derivatives containing a pyrimidine moiety

Abstract

A series of novel 1,2,4-triazole derivatives containing a pyrimidine moiety were synthesized and their fungicidal activities were evaluated. The preliminary biological test indicated that some of the target compounds exhibited moderate to good fungicidal activities against the tested plant pathogenic fungi compared with the commercial agent. Among them, compounds 9n and 9o exhibited excellent antifungal activity against Phompsis sp., with the half-maximal effective concentration (EC₅₀) values of 25.4 and 31.6?μg/mL, which were even better than the commercial agent of Pyrimethanil (32.1?μg/mL). Meanwhile, compound 9o showed better fungicidal activities against B. dothidea and B. cinerea with 40.1 and 55.1?μg/mL, respectively, in comparison with that of commercial Pyrimethanil (57.6 and 62.8?μg/mL).     

三唑并嘧啶类衍生物的合成及生物活性研究

Twelve [1,2,4]-triazolo[1,5-a]pyrimidine derivatives had been designed and synthesized by using substituted hydrazine hydrate as starting materials.The synthesized compounds were confirmed by elemental analysis,Infrared spectra and 1~H NMR techniques.Preliminary bioassay indicated that some of them displayed good herbicidal activities.     

Novel pyrimidine and its triazole fused derivatives: Synthesis and investigation of antioxidant and anti-inflammatory activity

In the present study, we have carried out the synthesis of novel dihydropyrimidinecarbonitrile (1a–c), its dimethylated adduct (2a–c), and hydrazine derivative (3a–c) of 2a–c and its triazole fused derivatives (4a–c, 5a–c and 6a–c). The structure of newly synthesized compounds was confirmed by IR, ¹H NMR, mass spectral data and elemental analysis. Further the novel derivatives were investigated for their in vitro antioxidant and anti-inflammatory activity. The results revealed that some of the tested compounds showed potent antioxidant and anti-inflammatory activity. The mass spectral pattern of 6a has been investigated in order to elucidate the structure.     

Syntheses,characterization, antibacterial activity and molecular modelling of phenylantimony(III) heteroleptic derivatives containing substituted oximes and piperidine dithiocarbamate

Six new heteroleptic phenylantimony(III) derivatives containing substituted oximes and dithiocarbamate moieties of the type (where R = ─C₆H₅, X = ─CH₃ ( 2a ); R = ─C₆H₄CH₃, X = ─CH₃ ( 2b ); R = ─C₆H₄Cl, X = ─CH₃ ( 2c ); R = ─C₆H₄Br, X = ─CH₃ ( 2d ); R = ─C₆H₄OH, X = ─H ( 2e ); R(X)C = ( 2f )) have been synthesized by the reactions of phenylantimony(III) dichloride with the sodium salt of substituted oximes and dithiocarbamate moiety in unimolar ratio with stirring in dichloromethane. All these newly synthesized derivatives have been characterized using physicochemical and elemental analyses. Structures have been proposed on the basis of infrared, ¹H NMR, ¹³C NMR and LC–MS spectral studies and molecular modelling. In these derivatives the oxime behaves in an unidentate manner whereas dithiocarbamate behaves in a monofunctional anisobidentate manner. Pseudo‐trigonal bipyramidal (ψ‐TBP) geometry around the antimony metal centre is proposed for these phenylantimony(III) heteroleptic derivatives. The geometry of a representative complex has been optimized through molecular modelling. These newly synthesized derivatives were screened against Bacillus subtilis (Gram‐positive) and Escherichia coli (Gram‐negative) bacteria to evaluate their antibacterial potential. The structure–activity relationship for antibacterial activity among the four derivatives 2a , 2c , 2e and 2f is discussed.     

Facile synthesis and antitumor activity of novel 2-trifluoromethylthieno[2,3-d]pyrimidine derivatives

A series of novel 2-trifluoromethylthieno[2,3-d]pyrimidine derivatives were synthesized by a facile three-step procedure that afforded advantages of mild reaction conditions, simple protocol and good yields. The structures of the final compounds were confirmed by 1R, NMR, El-MS, elemental analysis, and X-ray diffraction. Preliminary bioassay results showed that some of the analogs exhibit excellent antitumor activity against MCF-7 and HepG2, especially compounds 3a, 3b, 3e and 3h exhibited higher activity than the positive control gefitinib.     

硫色烯并噻唑胺类衍生物对乙酰胆碱酶抑制活性的QSAR模型*

基于化学拓扑理论,计算20 种硫色烯并噻唑胺类衍生物分子的电性距离矢量指数(m_t)。经最佳变量子集回归方法建立上述分子对电鳗乙酰胆碱酶体外抑制活性(pM)与m_t的最佳三元QSAR模型,其判定系数(R₂)和逐一剔除法交叉验证系数R_cv2依次为0.936和0.850。通过R₂、R_adj2、F、R_cv2、V_IF、A_IC、F_IT等检验,该模型具有令人满意的稳健性和预测能力。依据模型建议硫色烯并噻唑胺类衍生物对电鳗乙酰胆碱酶体外抑制的可能机理：分子疏水性起到主要及正向作用,氢键则起次要且为负向作用。     

螺环吲哚类MDM2抑制剂的分子对接、定量构效关系和分子动力学模拟

采用分子对接、三维定量构效关系(3D-QSAR)和分子动力学方法研究了21个螺环吲哚类化合物与MDM2蛋白的相互作用, 并建立了相关预测模型. 比较分子场分析法(CoMFA)和比较分子相似性指数分析法(CoMSIA)模型的交互验证相关系数q²分别为0.573 和0.651, 非交互验证相关系数r²分别为0.948和0.980. 分子对接得到的结合模式与分子动力学模拟得到的结果一致, 结合模式表明该类螺环吲哚化合物主要通过疏水相互作用和氢键与MDM2结合. 基于上述相互作用模型设计并合成了6个新结构螺环吲哚化合物, 并在MDM2高表达的前列腺癌LNCaP细胞株上测定其活性, 结果表明化合物5, 6的半数抑制浓度均低于1μg·mL^-1, 可作为新的抗肿瘤药物先导化合物进一步深入研究. 本研究对以MDM2为靶点的新结构螺环吲哚类抑制剂的开发提供了理论和实验依据.